Short-Term Pilot Study to Evaluate the Impact of Salbi Educa Nutrition App in Macronutrients Intake and Adherence to the Mediterranean Diet: Randomized Controlled Trial.
Marina Gonzalez-RamirezRocio Sanchez-CarreraAngela Cejudo-LopezMauricio Lozano-NavarreteElena Salamero Sánchez-GabrielM Alfonso Torres-BengoaManuel Segura-BalbuenaMaria J Sanchez-CorderoMercedes Barroso-VazquezFrancisco J Perez-BarbaAna M TroncosoMaria Carmen García-ParrillaAna B CerezoPublished in: Nutrients (2022)
Promoting a healthy diet is a relevant strategy for preventing non-communicable diseases. This study aims to evaluate the impact of an innovative tool, the SAlBi educa nutrition app, in primary healthcare dietary counseling to improve dietary profiles as well as adherence to the Mediterranean diet. A multi-center randomized control trial comprising 104 participants was performed. Both control ( n = 49) and intervention ( n = 55) groups attended four once-weekly sessions focusing on healthy eating habits and physical activity, over one month. As well as attending the meetings, the intervention group used the app, which provides self-monitoring and tailored dietary advice based on the Mediterranean diet model. In a second intervention (one arm trial), the potential of SAlBi educa was evaluated for three months during the COVID-19 pandemic. At 4 weeks, the intervention group had significantly increased their carbohydrate intake (7.7% (95% CI: 0.16 to 15.2)) and decreased their total fat intake (-5.7% (95% CI: -10.4 to -1.15)) compared to the control group. Significant differences were also found for carbohydrates (3.5% (95% CI: -1.0 to 5.8)), total fats (-5.9% (95% CI: -8.9 to -3.0)), fruits and vegetables (266.3 g/day (95% CI: 130.0 to 402.6)), legumes (7.7g/day (95% CI: 0.2 to 15.1)), starchy foods (36.4 g/day (95% CI: 1.1 to 71.7)), red meat (-17.5 g/day (95% CI: -34.0 to -1.1)), and processed meat (-6.6 g/day (95% CI: -13.1 to -0.1)) intakes during the COVID-19 pandemic. SAlBi educa is a useful tool to support nutrition counseling in primary healthcare, including in special situations such as the COVID-19 pandemic. Trial registration: ISRCTN57186362.
Keyphrases
- randomized controlled trial
- physical activity
- healthcare
- study protocol
- phase iii
- clinical trial
- phase ii
- adipose tissue
- smoking cessation
- weight loss
- open label
- hepatitis c virus
- systematic review
- weight gain
- heavy metals
- skeletal muscle
- human immunodeficiency virus
- climate change
- placebo controlled
- antiretroviral therapy
- preterm birth
- gestational age